摘要
长链非编码RNA HOXA11反义RNA(HOXA11-AS)是一种近年来发现的lncRNA。最早使用探针在小鼠胚胎c DNA文库中发现HOXA11-AS,随后在人宫颈癌、胃癌及神经胶质瘤等恶性肿瘤细胞中相继被学者发现并在其中发挥重要作用。HOXA11-AS能够通过与miRNA和EZH2蛋白等相互作用促进肿瘤的增殖、转移等恶性生物学行为,被认为是致癌性lncRNA。HOXA11-AS的发现为肿瘤的防治提供了新的思路。
The long noncoding RNA HOXA11 antisense RNA( HOXA11-AS) was recently discovered in a mouse embryo c DNA library using the probe from the sense HOXA11 c DNA sequence. Since then,it has been found to play important roles in human cervical cancer,gastric cancer,and gliomas. HOXA11-AS can promote tumor malignancy( i.e.,proliferation and metastasis) by interacting with various miRNAs and proteins such as EZH2,providing new potential routes for the potential treatment of cancers.
引文
[1] Cox AD, Fesik SW, Kimmelman AC, et al. Drugging the undruggable RAS:Mission possible?[J]. Nat Rev Drug Discov,2014,13(11):828-851.
[2]贡时雨,范慧敏,张旭敏,等. LncRNA在心力衰竭预后判断和治疗中的潜力研究进展[J].中国比较医学杂志,2018,28(2):102-105.
[3]罗文浩,张培东. ciRS-7在心血管类疾病中的研究进展[J].中国比较医学杂志,2018,28(4):127-130.
[4]刘萍,赵海苹,罗玉敏. MicroRNA-424在肿瘤发生中的作用和机制研究进展[J].中国实验动物学报,2016,24(5):529-534.
[5] Gómezmaldonado L,Tiana M,Roche O,et al. EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination[J]. Oncogene,2014,34(20):2609-2620.
[6]刘丽云,龚健,徐晋珩,等.长链非编码RNA CCAT1对人乳头状甲状腺癌侵袭和迁移能力的影响[J].中国比较医学杂志,2017,27(7):81-86.
[7] Siegel RL,Miller KD. Cancer Statistics,2017[J]. Ca-Cancer J Clin,2017,67(1):7-30.
[8] Mu S,Ai L,Fan F,et al. Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors:a meta-analysis[J]. Cancer Cell Int,2018,18:1.
[9] Li N,Yang ML,Shi K,et al. Long non-coding RNA HOXA11-AS in human cancer:A meta-analysis[J]. Clin Chim Acta,2017,474:165-170.
[10] Zhang Y,He RQ,Dang YW,et al. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells[J]. Cancer Cell Int,2016,16:89.
[11] Xue JY,Huang C,Wang W,et al. HOXA11-AS:a novel regulator in human cancer proliferation and metastasis[J]. Onco Targets Ther,2018,11:4387-4393.
[12] Chau YM, Pando S, Taylor HS. HOXA11 silencing and endogenous HOXA11 antisense ribonucleic acid in the uterine endometrium[J]. J Clin Endocr Metab,2002,87(6):2674-2680.
[13] Lu SN,Jiang XM,Su ZL,et al. The role of the long non-coding RNA HOXA11-AS in promoting proliferation and metastasis of malignant tumors[J]. Cell Biol Int,2018.[Epub ahead of print]
[14] Cui Y,Yi L,Zhao JZ,et al. Long noncoding RNA HOXA11-AS functions as miRNA sponge to promote the glioma tumorigenesis through targeting miR-140-5p[J]. DNA Cell Biol,2017,36(10):822-828.
[15] Xu C,He T,Li Z,et al. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth,migration and invasion of glioma cells[J]. Biomed Pharmacother,2017,95:1504-1513.
[16] Wang Q,Zhang J,Liu Y,et al. A novel cell cycle-associated lncRNA,HOXA11-AS,is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma[J]. Cancer Lett,2016,373(2):251-259.
[17] Zhang ZX, Zhou JH, Zhang JX, et al. Downregulation of lncRNA-HOXA11-AS modulates proliferation and stemness in glioma cells[J]. Chinese Neurosurgical Journal,2017,3(4):198-204.
[18] Yang JX,Liu B,Yang BY,et al. Long non-coding RNA homeobox(HOX)A11-AS promotes malignant progression of glioma by targeting miR-124-3p[J]. Neoplasma,2018,65(4):505-514.
[19]高健伟,李鹰飞,徐豪明,等. HOXA11-AS在胃癌中的表达及其功能研究[J].胃肠病学和肝病学杂志,2017,26(12):1331-1335.
[20] Liu Z,Chen Z,Fan R,et al. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer[J]. Mol Cancer,2017,16(1):82.
[21] Sun M,Nie F,Wang Y,et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2,LSD1,and DNMT1[J].Cancer Res,2016,76(21):6299-6310.
[22] Li T,Xu C,Cai B,et al. Expression and clinicopathological significance of the lncRNA HOXA11-AS in colorectal cancer[J]. Oncol Lett,2016,12(5):4155-4160.
[23] Chen D,Sun Q,Zhang L,et al. The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2expression by sponging miR-125a-5p in liver metastasis of colorectal cancer[J]. Oncotarget,2017,8(41):70642-70652
[24] Zhang Y,Chen W,Gan T,et al. Clinical significance and effect of incRNA HOXA11-AS in NSCLC:a study based on bioinformatics,in vitro and in vivo verification[J]. Sci Rep,2017,7(1):5567.
[25] Chen JH,Zhou LY,Xu S,et al. Overexpression of lncRNA HOXA11-AS promotes cell epithelial-mesenchymal transition by repressing miR-200b in non-small cell lung cancer[J]. Cancer Cell Int,2017,17:64.
[26] Yu WJ,Peng WD,Jiang H,et al. LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells[J]. Tumour Biol,2017,39(10):1010428317721440.
[27] Zhang Y,Luo J,Wang X,et al. A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long noncoding RNA HOXA11-AS in NSCLC cells[J]. Oncol Lett,2018,15(5):6147-6160.
[28] Yu J,Hong JF,Kang J,et al. Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1[J]. Eur Rev Med Pharmaco,2017,21(15):3402-3411.
[29] Zhan MX,He K,Xiao J,et al. LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p[J]. J Cell Mol Med,2018,22(8):3758-3767.
[30] Liu B,Li J,Liu X,et al. Long non-coding RNA HOXA11-AS promotes the proliferation HCC cells by epigenetically silencing DUSP5[J]. Oncotarget,2017,8(65):109509-109521.
[31] Yang FQ,Zhang JQ,Jin JJ,et al. HOXA11-AS promotes the growth and invasion of renal cancer by sponging miR-146b-5p to upregulate MMP16 expression[J]. J Cell Physiol,2018,233(12):9611-9619.
[32] Richards EJ,Jennifer PW,Yajuan L,et al. A functional variant in HOXA11-AS,a novel long non-coding RNA,inhibits the oncogenic phenotype of epithelial ovarian cancer[J].Oncotarget,2015,6(33):34745-34757.
[33] Kim HJ,Eoh KJ,Kim LK,et al. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer[J]. Oncotarget,2016,7(50):83001-83016.
[34] Cui MX,Wang JY,Li QJ,et al. Long non-coding RNA HOXA11-AS functions as a competing endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p in osteosarcoma[J]. Biomed Pharmacother,2017,92:437-444.
[35]张鸿程,宋广元,谈伟健,等. lncRNA HOXA11-AS对骨肉瘤细胞增殖、迁移和侵袭能力的影响[J].中国肿瘤生物治疗杂志,2017,24(5):497-502.
[36] Li WL,Jia GT,Qu YW,et al. Long Non-Coding RNA(LncRNA)HOXA11-AS promotes breast cancer invasion and metastasis by regulating epithelial-mesenchymal transition[J].Med Sci Monitor,2017,23:3393-3403.
[37] Lu QK,Zhao N,Zha GP,et al. LncRNA HOXA11-AS exerts oncogenic functions by repressing p21 and miR-124 in uveal melanoma[J]. DNA Cell Biol,2017,36(10):837-844.
[38]孙晓燕,王晓飞,崔渊博,等.长链非编码RNA HOXA11-AS在食管鳞癌中的表达及意义[J].中华肿瘤杂志,2018,40(3):186-190.
[39] Qu LM,Jin M,Yang LK,et al. Expression of long non-coding RNA HOXA11-AS is correlated with progression of laryngeal squamous cell carcinoma[J]. Am J Transl Res,2018,10(2):573-580.
[40] Zhao X,Li X,Zhou L,et al. LncRNA HOXA11-AS drives cisplatin-resistance of human LUAD cells via modulating miR-454-3p/Stat3[J]. Cancer Sci,2018,109(10):3068-3079.